Quarterly report pursuant to Section 13 or 15(d)

Shareholders Equity (Details 1)

v3.20.1
Shareholders Equity (Details 1)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2020
USD ($)
$ / shares
shares
Number of Options  
Outstanding, beginning balance 3,143,802
Granted 814,700
Forfeited (16,747)
Exercised (57,325)
Outstanding, ending balance 3,884,430
Vested at end of period 1,654,090
Weighted average remaining contractual life 6 years 11 months 15 days
Weighted average exercise price  
Outstanding, beginning balance | $ / shares $ 1.09
Granted | $ / shares 6.21
Forfeited | $ / shares 1.69
Exercised | $ / shares 1.85
Outstanding, ending balance | $ / shares $ 2.87
Aggregate intrinsic value  
Outstanding, beginning balance | $ $ 25,733
Outstanding, ending balance | $ $ 16,035